Last reviewed · How we verify
Haemophilus influenza type b conjugate vaccine — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
Haemophilus influenza type b conjugate vaccine (Haemophilus influenza type b conjugate vaccine) — Novartis Vaccines.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Haemophilus influenza type b conjugate vaccine TARGET | Haemophilus influenza type b conjugate vaccine | Novartis Vaccines | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Haemophilus influenza type b conjugate vaccine CI watch — RSS
- Haemophilus influenza type b conjugate vaccine CI watch — Atom
- Haemophilus influenza type b conjugate vaccine CI watch — JSON
- Haemophilus influenza type b conjugate vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Haemophilus influenza type b conjugate vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/haemophilus-influenza-type-b-conjugate-vaccine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab